Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia

Published:2001-01 Issue:2 Volume:27 Page:225-227
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Jándula BM,Nomdedeu J,Marín P,Vivancos P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1702706.pdf

Reference11 articles.

1. Hoelzer D . Treatment of acute lymphoblastic leukemia Semin Hematol 1994 31: 1–15

2. Atta J, Fauth F, Keyser M et al. Purging in BCR-ABL-positive acute lymphoblastic leukemia using inmunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction Bone Marrow Transplant 2000 25: 97–104

3. Canals C, Picón M, Sanchez T et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging Prog Clin Biol Res 1994 389: 125–132

4. Gockbuget N, Arnold R, Büchner T et al. Treatment of adult acute lymphoblastic leukemia Schweiz Rundsch Med Prax 1999 88: 407–420

5. Sierra J, Radich J, Hansen JA et al. Marrow transplant from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1997 90: 1410–1414

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies Targeting Hematological Malignancies;Immunotherapy for Pediatric Malignancies;2017-11-22

2. Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?;Current Hematologic Malignancy Reports;2017-02-18

3. Novel approaches to pediatric leukemia treatment;Expert Review of Anticancer Therapy;2015-05-23

4. Toward effective targeted therapy for the treatment of adult acute lymphoblastic leukemia;International Journal of Hematologic Oncology;2015-03

5. Humoral and Cellular Immunotherapy in ALL in Children, Adolescents, and Young Adults;Clinical Lymphoma Myeloma and Leukemia;2014-09